Home › Calculator › CLVLF Dividend Calculator 2026
CLVLF DRIP Calculator & Dividend Yield 2026
0.71% YieldHealthcareClinuvel Pharmaceuticals Limited · OTC
Price: $5.05 · Annual div: $0.0360/share · Frequency: annual · Payout ratio: 5% · Ex-div: 2026-09-04
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
CLVLF Dividend Yield
CLVLF (Clinuvel Pharmaceuticals Limited) has a dividend yield of 0.71%, based on an annual dividend of $0.0360 per share and a price of $5.05. Over the last 12 months it paid $0.0360 per share — a trailing yield of 0.71%. Dividends are paid annual.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CLVLF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
CLVLF Dividend History — Last 9 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-09-04Latest | 2026-09-18 | $0.0360 | 1.16% | $5.92 |
| 2025-09-05 | 2025-09-19 | $0.0328 | 0.39% | $8.50 |
| 2024-09-05 | 2024-09-20 | $0.0334 | 0.29% | $11.46 |
| 2023-09-05 | 2023-09-20 | $0.0319 | 0.46% | $12.68 |
| 2022-09-06 | 2022-09-21 | $0.0269 | 0.21% | $12.62 |
| 2021-09-02 | 2021-09-17 | $0.0185 | 0.14% | $26.19 |
| 2020-09-03 | 2020-09-18 | $0.0182 | — | — |
| 2019-09-04 | 2019-09-19 | $0.0170 | — | — |
| 2018-09-21 | 2018-10-08 | $0.0146 | — | — |
About Clinuvel Pharmaceuticals Limited (CLVLF) — Dividend Analysis 2026
Clinuvel Pharmaceuticals Limited (CLVLF), an Australian biopharmaceutical firm established in Melbourne in 1987, specializes in the creation and global marketing of therapeutic solutions. Its primary focus is on patients suffering from genetic, metabolic, and severe, life-threatening conditions, with operations spanning Australia, Europe, the United States, Switzerland, and various international markets. The company's flagship product is SCENESSE, a systemic photoprotective medication. This drug is specifically designed to prevent light-induced damage in adult individuals diagnosed with erythropoietic protoporphyria (EPP). Beyond its established product, Clinuvel's development pipeline encompasses several other promising compounds. These include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which is recognized for its ability to provoke heightened and sustained cellular activity; and PRÉNUMBRA, an injectable liquid formulation of afamelanotide. Furthermore, Clinuvel has forged a strategic partnership with HK Winhealth Pharma Group Co. Limited. This collaboration aims to provide SCENESSE to EPP patients in the People's Republic of China via a dedicated named patient program.
Similar dividend stocks to CLVLF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CLVLF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CLVLF position with:
🌍 CLVLF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CLVLF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.71% | -2.09% | $71 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.60% | -2.20% | $60 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.57% | -2.23% | $57 / yr |
| 🇬🇧 UK ISA | 0% | 0.71% | -2.09% | $71 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.65% | -2.15% | $65 / yr |
| 🇨🇦 TFSA | 0% | 0.71% | -2.09% | $71 / yr |
| 🇨🇦 CA Taxable | 25% | 0.53% | -2.27% | $53 / yr |
| 🇦🇺 Super (pension) | 15% | 0.60% | -2.20% | $60 / yr |
| 🇦🇺 AU Taxable | 30% | 0.50% | -2.30% | $50 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.52% | -2.28% | $52 / yr |
| 🇫🇷 FR Taxable | 30% | 0.50% | -2.30% | $50 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CLVLF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.04/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CLVLF Dividend Payment Schedule
CLVLF pays annually — 1 payment per year.
📊 CLVLF vs Healthcare Benchmarks
How CLVLF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CLVLF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CLVLF Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare CLVLF with peers: CLVLF vs CMVLF · CLVLF vs CYDY · CLVLF vs EAPIF
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CLVLF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Clinuvel Pharmaceuticals Limited (CLVLF) is currently trading at $5.05, trading near its 52-week low. The current dividend yield is 0.71% based on an annual payout of $0.0360 per share.
CLVLF (Clinuvel Pharmaceuticals Limited) — 0.71% Dividend Yield Analysis
Clinuvel Pharmaceuticals Limited (CLVLF) is a healthcare stock currently trading at $5.05 with a dividend yield of 0.71%. It pays an annual dividend of $0.0360 per share. The payout ratio of 5% suggests the dividend is well-covered by earnings. Over the past 5 years, CLVLF has grown its dividend at a compound annual rate of 14.9%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CLVLF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the CLVLF dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.